BiotechTube

ABBV-950 + BOTOX + Placebo for ABBV-950

Phase 1Terminated
0 views this week 0 watching💤 Quiet
Interest: 21/100
21
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Upper Limb Spasticity

Conditions

Upper Limb Spasticity

Trial Timeline

Jan 12, 2024 → Jun 2, 2024

NCT ID
NCT05956509

About ABBV-950 + BOTOX + Placebo for ABBV-950

ABBV-950 + BOTOX + Placebo for ABBV-950 is a phase 1 stage product being developed by AbbVie for Upper Limb Spasticity. The current trial status is terminated. This product is registered under clinical trial identifier NCT05956509. Target conditions include Upper Limb Spasticity.

What happened to similar drugs?

6 of 15 similar drugs in Upper Limb Spasticity were approved

Approved (6) Terminated (1) Active (9)
✅Remimazolam TosilateJiangsu Hengrui MedicineApproved
✅BOTOXAbbVieApproved
✅Montelukast + PlaceboMerckApproved
🔄Muntelukast + PlaceboMerckPhase 3
🔄IFF flavor 316 282, Paracetamol, PseudoephedrineNovartisPhase 3
🔄Paracetamol (500 mg)/dimethindene maleate (1 mg)/ phenylephrine hydrochloride (10 mg) tablets + Paracetamol (500 mg) tabletsNovartisPhase 3
✅diclofenac potassium + nimesulideNovartisApproved

Hype Score Breakdown

Clinical
6
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT05956509Phase 1Terminated

Competing Products

20 competing products in Upper Limb Spasticity

See all competitors
ProductCompanyStageHype Score
Nivolumab 100 MG in 10 ML InjectionOno PharmaceuticalPhase 2
31
Remimazolam TosilateJiangsu Hengrui MedicineApproved
43
BOTOX + Placebo for BOTOXAbbViePhase 2
35
BOTOXAbbVieApproved
43
MK-3475 and BCGMerckPhase 2
42
Montelukast + PlaceboMerckApproved
43
Muntelukast + PlaceboMerckPhase 3
36
IFF flavor 316 282, Paracetamol, PseudoephedrineNovartisPhase 3
40
Paracetamol (500 mg)/dimethindene maleate (1 mg)/ phenylephrine hydrochloride (10 mg) tablets + Paracetamol (500 mg) tabletsNovartisPhase 3
40
diclofenac potassium + nimesulideNovartisApproved
35
Diclofenac gelNovartisApproved
43
IFF flavor 316 282, Paracetamol , Phenylephrine, GuaifenesinNovartisPhase 3
40
Domvanalimab + Zimberelimab + Capecitabine + Fluorouracil + Leucovorin + Oxaliplatin + NivolumabGilead SciencesPhase 3
44
Azithromycin SRPfizerPhase 3
40
NivolumabBristol Myers SquibbPre-clinical
26
NivolumabBristol Myers SquibbPre-clinical
26
REGN475/SAR164877 + Placebo (for REGN475/SAR164877)Regeneron PharmaceuticalsPhase 2
27
IPN10200 + IPN10200 Placebo + DysportIpsenPhase 1/2
36
AboBoNT-A + OnaBoNT-AIpsenApproved
40
Botulinum toxin type AIpsenPhase 3
37